Post-stroke Fatigue and Clinical Parameters

NCT ID: NCT07231172

Last Updated: 2025-11-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

107 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-11-21

Study Completion Date

2026-01-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to determine the frequency of post-stroke fatigue (PSF) in patients experiencing their first-ever stroke and admitted to our clinic. PSF is a common and debilitating condition that significantly impacts patients' recovery and quality of life. The study will also explore the association between fatigue severity and various demographic and clinical factors such as age, gender, stroke type and duration, pain, mood disorders, sleep quality, motor and cognitive functions, spasticity, physical capacity, ambulation, independence in daily living activities, and health-related quality of life. Patients over 18 years old, at least three months post-stroke, and meeting specific inclusion criteria will be recruited. Fatigue will be assessed using validated scales including the Fatigue Severity Scale and Visual Analog Scale-Fatigue. Additional assessments will measure pain, anxiety, depression, sleep disturbances, motor and cognitive status, spasticity, physical endurance, functional mobility, and daily activity independence. The findings are expected to contribute to a better understanding of PSF and help inform more effective rehabilitation strategies.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

According to the definition of the World Health Organization, stroke is defined as "rapidly developing clinical manifestations of focal (or global) impairment of cerebral function that lasts longer than 24 hours or may result in death and has no apparent cause other than vascular origin". Stroke is the second leading cause of death in the world. It is also the leading cause of disability and accounts for a significant proportion of hospital admissions and health expenditures in industrialized societies. Stroke has many complications, one of which is fatigue. Fatigue can be defined as a decrease in physical and/or mental performance resulting from changes in central, psychological and/or environmental factors. Normal fatigue is a generalized state of tiredness resulting from overexertion and improves with rest. In contrast, "pathologic fatigue", often experienced by patients with neurological disorders, is chronic fatigue unrelated to previous levels of exertion and usually does not improve with rest. Post-stroke fatigue can be considered as a type of pathologic fatigue. Post-stroke fatigue is one of the most common symptoms 3 months after stroke. Half of the patients may still experience fatigue 1 year after stroke and this condition may last for years. The prevalence of post-stroke fatigue has been reported to vary between 39% and 68%. Post-stroke fatigue negatively affects the quality of life of stroke patients and constitutes a significant barrier to recovery, especially in participation in rehabilitation programs. Therefore, understanding post-stroke fatigue is an important issue for healthcare professionals in terms of implementing effective rehabilitation programs in patients with stroke. However, little is known about the etiology and effective management of post-stroke fatigue. Numerous factors have been shown to be associated with post-stroke fatigue, including age, gender, depression, stroke severity, stroke type and lesion location, pain, but these risk factors are not consistent across all studies. The lack of appropriate objective measurement tools may be one of the reasons for the poor understanding of post-stroke fatigue. Several tools are available to assess fatigue, including the Fatigue Rating Scale, Fatigue Impact Scale, Fatigue Severity Scale (FSS) and Visual Analogue Scale-Fatigue. The Fatigue Severity Scale (FSS) is the most commonly used fatigue assessment scale in stroke patients and was originally developed to measure fatigue in patients with Multiple Sclerosis and Systemic Lupus Erythematosus. In the literature, there are studies investigating the frequency of fatigue after stroke and its relationship with various demographic and clinical parameters. In our country, there are a few studies evaluating the frequency of fatigue after stroke. There is no complete clarity in terms of both the frequency and the factors associated with fatigue in the studies. Our primary aim in this study is to determine the frequency of post-stroke fatigue in first-time stroke patients admitted to our clinic. Our secondary aim is to evaluate the relationship between fatigue severity and demographic and clinical characteristics of the patients such as age, gender, education level, stroke type, stroke duration and severity of pain, anxiety, depression, sleep status, motor and cognitive function, spasticity, physical capacity, functional ambulation, level of independence in activities of daily living and health-related quality of life.

Method: The study will include patients who were diagnosed with stroke for the first time according to the World Health Organization definition, who were over 18 years of age, whose general condition was stable after stroke and at least 3 months have passed since the event, among the patients followed up in the Department of Physical Medicine and Rehabilitation of Ankara University Faculty of Medicine Ibn-i Sina and Cebeci hospitals. This study will be conducted within the scope of good clinical practices and all patients will be asked to give consent to the study by reviewing the informed consent form before the study.

Inclusion Criteria:

* Being diagnosed with stroke according to definition by the World Health Organization
* Being over 18 years of age
* Having had a stroke confirmed by Computed Tomography (CT) and/or Magnetic Resonance Imaging (MRI)
* At least 3 months after stroke
* At least stage 2 according to the Functional Ambulation Classification
* Agreed to participate in the study and signed the informed consent form

Exclusion Criteria:

* Previous history of stroke
* Communication problems due to reasons such as aphasia and dementia
* Patients who are illiterate
* Cognitive functional impairment who cannot take commands (MMSE\<24)
* Dİagnoses such as cancer, heart failure, liver failure, renal failure that may cause fatigue
* Signs of systemic infection
* History of subarachnoid hemorrhage

Demographic information (gender, age, height, weight, body mass index, occupation), medical history, type of lesion (ischemic, hemorrhagic), duration of disease, laboratory values such as vitamin B12, vitamin D, hemoglobin and albumin levels and current treatments will be obtained from the patients who agree to participate in the study and meet the inclusion criteria and this information will be recorded in the patient follow-up form. Fatigue Severity Scale (FSS) will be used to assess fatigue after stroke. In addition, the Visual Analog Scale-Fatigue (VAS-Fatigue) will be used to determine the severity of fatigue. Pain severity will be assessed using the Visual Analog Scale-Pain (VAS-Pain), depression and anxiety will be assessed using the Hospital Anxiety and Depression Scale, sleep quality will be assessed using the Athens Insomnia Scale, motor function will be assessed using the Brunnstrom Motor Recovery Staging, and cognitive function will be assessed using the Mini Mental State Examination and Montreal Cognitive Assessment. The level of spasticity will be assessed with the Modified Ashworth Scale, physical capacity with the 6-minute walk test, functional ambulation with the Functional Ambulation Classification, independence in activities of daily living with the Modified Barthel Index, and health-related quality of life with the Stroke Impact Scale v3.0

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Stroke Fatigue Poststroke Fatigue

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

CROSS_SECTIONAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Being diagnosed with stroke according to definition by the World Health Organization
* Being over 18 years of age
* Having had a stroke confirmed by Computed Tomography (CT) and/or Magnetic Resonance Imaging (MRI)
* At least 3 months after stroke
* At least stage 2 according to the Functional Ambulation Classification
* Agreed to participate in the study and signed the informed consent form

Exclusion Criteria

* Previous history of stroke
* Communication problems due to reasons such as aphasia and dementia
* Patients who are illiterate
* Cognitive functional impairment who cannot take commands (MMSE\<24)
* Dİagnoses such as cancer, heart failure, liver failure, renal failure that may cause fatigue
* Signs of systemic infection
* History of subarachnoid hemorrhage
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ankara University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ayşe A Küçükdeveci, MD

Clinical Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ayşe A. Küçükdeveci, Prof

Role: PRINCIPAL_INVESTIGATOR

Ankara University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ankara University

Ankara, , Turkey (Türkiye)

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Mehmet Tekeş, MD

Role: CONTACT

+903125082822

Ayşe A. Küçükdeveci, MD, Prof

Role: CONTACT

+903125082822

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Mehmet Tekeş, MD

Role: primary

+903125082822

Ayşe A. Küçükdeveci, MD, Prof

Role: backup

+903125082822

References

Explore related publications, articles, or registry entries linked to this study.

Hubacher M, Calabrese P, Bassetti C, Carota A, Stocklin M, Penner IK. Assessment of post-stroke fatigue: the fatigue scale for motor and cognitive functions. Eur Neurol. 2012;67(6):377-84. doi: 10.1159/000336736. Epub 2012 May 17.

Reference Type RESULT
PMID: 22614741 (View on PubMed)

Duncan PW, Bode RK, Min Lai S, Perera S; Glycine Antagonist in Neuroprotection Americans Investigators. Rasch analysis of a new stroke-specific outcome scale: the Stroke Impact Scale. Arch Phys Med Rehabil. 2003 Jul;84(7):950-63. doi: 10.1016/s0003-9993(03)00035-2.

Reference Type RESULT
PMID: 12881816 (View on PubMed)

Duncan PW, Wallace D, Lai SM, Johnson D, Embretson S, Laster LJ. The stroke impact scale version 2.0. Evaluation of reliability, validity, and sensitivity to change. Stroke. 1999 Oct;30(10):2131-40. doi: 10.1161/01.str.30.10.2131.

Reference Type RESULT
PMID: 10512918 (View on PubMed)

Kucukdeveci AA, Yavuzer G, Tennant A, Suldur N, Sonel B, Arasil T. Adaptation of the modified Barthel Index for use in physical medicine and rehabilitation in Turkey. Scand J Rehabil Med. 2000 Jun;32(2):87-92.

Reference Type RESULT
PMID: 10853723 (View on PubMed)

Shah S, Vanclay F, Cooper B. Improving the sensitivity of the Barthel Index for stroke rehabilitation. J Clin Epidemiol. 1989;42(8):703-9. doi: 10.1016/0895-4356(89)90065-6.

Reference Type RESULT
PMID: 2760661 (View on PubMed)

Mehrholz J, Wagner K, Rutte K, Meissner D, Pohl M. Predictive validity and responsiveness of the functional ambulation category in hemiparetic patients after stroke. Arch Phys Med Rehabil. 2007 Oct;88(10):1314-9. doi: 10.1016/j.apmr.2007.06.764.

Reference Type RESULT
PMID: 17908575 (View on PubMed)

Holden MK, Gill KM, Magliozzi MR, Nathan J, Piehl-Baker L. Clinical gait assessment in the neurologically impaired. Reliability and meaningfulness. Phys Ther. 1984 Jan;64(1):35-40. doi: 10.1093/ptj/64.1.35.

Reference Type RESULT
PMID: 6691052 (View on PubMed)

Macchiavelli A, Giffone A, Ferrarello F, Paci M. Reliability of the six-minute walk test in individuals with stroke: systematic review and meta-analysis. Neurol Sci. 2021 Jan;42(1):81-87. doi: 10.1007/s10072-020-04829-0. Epub 2020 Oct 16.

Reference Type RESULT
PMID: 33064231 (View on PubMed)

Bohannon RW, Smith MB. Interrater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther. 1987 Feb;67(2):206-7. doi: 10.1093/ptj/67.2.206.

Reference Type RESULT
PMID: 3809245 (View on PubMed)

Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005 Apr;53(4):695-9. doi: 10.1111/j.1532-5415.2005.53221.x.

Reference Type RESULT
PMID: 15817019 (View on PubMed)

Bour A, Rasquin S, Boreas A, Limburg M, Verhey F. How predictive is the MMSE for cognitive performance after stroke? J Neurol. 2010 Apr;257(4):630-7. doi: 10.1007/s00415-009-5387-9. Epub 2009 Nov 22.

Reference Type RESULT
PMID: 20361295 (View on PubMed)

Elhan AH, Kutlay S, Kucukdeveci AA, Cotuk C, Ozturk G, Tesio L, Tennant A. Psychometric properties of the Mini-Mental State Examination in patients with acquired brain injury in Turkey. J Rehabil Med. 2005 Sep;37(5):306-11. doi: 10.1080/16501970510037573.

Reference Type RESULT
PMID: 16203619 (View on PubMed)

Gungen C, Ertan T, Eker E, Yasar R, Engin F. [Reliability and validity of the standardized Mini Mental State Examination in the diagnosis of mild dementia in Turkish population]. Turk Psikiyatri Derg. 2002 Winter;13(4):273-81. Turkish.

Reference Type RESULT
PMID: 12794644 (View on PubMed)

Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975 Nov;12(3):189-98. doi: 10.1016/0022-3956(75)90026-6. No abstract available.

Reference Type RESULT
PMID: 1202204 (View on PubMed)

Brunnstrom S. Motor testing procedures in hemiplegia: based on sequential recovery stages. Phys Ther. 1966 Apr;46(4):357-75. doi: 10.1093/ptj/46.4.357. No abstract available.

Reference Type RESULT
PMID: 5907254 (View on PubMed)

Elbi H, Batum M, Ozturk EO, Balcan MV, Ak AK, Yilmaz H, Aydemir O. Adaptation into Turkish and Psychometric Properties of Athens Insomnia Scale. Noro Psikiyatr Ars. 2024 Apr 1;61(2):154-159. doi: 10.29399/npa.28575. eCollection 2024.

Reference Type RESULT
PMID: 38868854 (View on PubMed)

Soldatos CR, Dikeos DG, Paparrigopoulos TJ. Athens Insomnia Scale: validation of an instrument based on ICD-10 criteria. J Psychosom Res. 2000 Jun;48(6):555-60. doi: 10.1016/s0022-3999(00)00095-7.

Reference Type RESULT
PMID: 11033374 (View on PubMed)

Aben I, Verhey F, Lousberg R, Lodder J, Honig A. Validity of the beck depression inventory, hospital anxiety and depression scale, SCL-90, and hamilton depression rating scale as screening instruments for depression in stroke patients. Psychosomatics. 2002 Sep-Oct;43(5):386-93. doi: 10.1176/appi.psy.43.5.386.

Reference Type RESULT
PMID: 12297607 (View on PubMed)

Snaith RP. The Hospital Anxiety And Depression Scale. Health Qual Life Outcomes. 2003 Aug 1;1:29. doi: 10.1186/1477-7525-1-29.

Reference Type RESULT
PMID: 12914662 (View on PubMed)

Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983 Jun;67(6):361-70. doi: 10.1111/j.1600-0447.1983.tb09716.x.

Reference Type RESULT
PMID: 6880820 (View on PubMed)

Revill SI, Robinson JO, Rosen M, Hogg MI. The reliability of a linear analogue for evaluating pain. Anaesthesia. 1976 Nov;31(9):1191-8. doi: 10.1111/j.1365-2044.1976.tb11971.x.

Reference Type RESULT
PMID: 1015603 (View on PubMed)

Choi-Kwon S, Han SW, Kwon SU, Kim JS. Poststroke fatigue: characteristics and related factors. Cerebrovasc Dis. 2005;19(2):84-90. doi: 10.1159/000082784. Epub 2004 Dec 17.

Reference Type RESULT
PMID: 15608431 (View on PubMed)

Okuyama T, Akechi T, Kugaya A, Okamura H, Shima Y, Maruguchi M, Hosaka T, Uchitomi Y. Development and validation of the cancer fatigue scale: a brief, three-dimensional, self-rating scale for assessment of fatigue in cancer patients. J Pain Symptom Manage. 2000 Jan;19(1):5-14. doi: 10.1016/s0885-3924(99)00138-4.

Reference Type RESULT
PMID: 10687321 (View on PubMed)

Bodian CA, Freedman G, Hossain S, Eisenkraft JB, Beilin Y. The visual analog scale for pain: clinical significance in postoperative patients. Anesthesiology. 2001 Dec;95(6):1356-61. doi: 10.1097/00000542-200112000-00013.

Reference Type RESULT
PMID: 11748392 (View on PubMed)

Miller KK, Combs SA, Van Puymbroeck M, Altenburger PA, Kean J, Dierks TA, Schmid AA. Fatigue and pain: relationships with physical performance and patient beliefs after stroke. Top Stroke Rehabil. 2013 Jul-Aug;20(4):347-55. doi: 10.1310/tsr2004-347.

Reference Type RESULT
PMID: 23893834 (View on PubMed)

Ozyemisci-Taskiran O, Batur EB, Yuksel S, Cengiz M, Karatas GK. Validity and reliability of fatigue severity scale in stroke. Top Stroke Rehabil. 2019 Mar;26(2):122-127. doi: 10.1080/10749357.2018.1550957. Epub 2018 Nov 26.

Reference Type RESULT
PMID: 30475156 (View on PubMed)

Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol. 1989 Oct;46(10):1121-3. doi: 10.1001/archneur.1989.00520460115022.

Reference Type RESULT
PMID: 2803071 (View on PubMed)

Nadarajah M, Goh HT. Post-stroke fatigue: a review on prevalence, correlates, measurement, and management. Top Stroke Rehabil. 2015 Jun;22(3):208-20. doi: 10.1179/1074935714Z.0000000015. Epub 2015 Mar 17.

Reference Type RESULT
PMID: 25779764 (View on PubMed)

Hinkle JL, Becker KJ, Kim JS, Choi-Kwon S, Saban KL, McNair N, Mead GE; American Heart Association Council on Cardiovascular and Stroke Nursing and Stroke Council. Poststroke Fatigue: Emerging Evidence and Approaches to Management: A Scientific Statement for Healthcare Professionals From the American Heart Association. Stroke. 2017 Jul;48(7):e159-e170. doi: 10.1161/STR.0000000000000132. Epub 2017 May 25.

Reference Type RESULT
PMID: 28546322 (View on PubMed)

Elbers RG, Rietberg MB, van Wegen EE, Verhoef J, Kramer SF, Terwee CB, Kwakkel G. Self-report fatigue questionnaires in multiple sclerosis, Parkinson's disease and stroke: a systematic review of measurement properties. Qual Life Res. 2012 Aug;21(6):925-44. doi: 10.1007/s11136-011-0009-2. Epub 2011 Oct 20.

Reference Type RESULT
PMID: 22012025 (View on PubMed)

Moos RH, Brennan PL, Schutte KK, Moos BS. Older adults' coping with negative life events: common processes of managing health, interpersonal, and financial/work stressors. Int J Aging Hum Dev. 2006;62(1):39-59. doi: 10.2190/ENLH-WAA2-AX8J-WRT1.

Reference Type RESULT
PMID: 16454482 (View on PubMed)

Blaauw E, Arensman E, Kraaij V, Winkel FW, Bout R. Traumatic life events and suicide risk among jail inmates: the influence of types of events, time period and significant others. J Trauma Stress. 2002 Feb;15(1):9-16. doi: 10.1023/A:1014323009493.

Reference Type RESULT
PMID: 11936726 (View on PubMed)

Tang WK, Chen YK, Liang HJ, Chu WC, Mok VC, Ungvari GS, Wong KS. Subcortical white matter infarcts predict 1-year outcome of fatigue in stroke. BMC Neurol. 2014 Dec 12;14:234. doi: 10.1186/s12883-014-0234-8.

Reference Type RESULT
PMID: 25496671 (View on PubMed)

Nadarajah M, Mazlan M, Abdul-Latif L, Goh HT. Test-retest reliability, internal consistency and concurrent validity of Fatigue Severity Scale in measuring post-stroke fatigue. Eur J Phys Rehabil Med. 2017 Oct;53(5):703-709. doi: 10.23736/S1973-9087.16.04388-4. Epub 2016 Oct 21.

Reference Type RESULT
PMID: 27768012 (View on PubMed)

Barker-Collo S, Feigin VL, Dudley M. Post stroke fatigue--where is the evidence to guide practice? N Z Med J. 2007 Oct 26;120(1264):U2780.

Reference Type RESULT
PMID: 17972987 (View on PubMed)

Chestnut TJ. Fatigue in stroke rehabilitation patients: a pilot study. Physiother Res Int. 2011 Sep;16(3):151-8. doi: 10.1002/pri.476. Epub 2010 May 18.

Reference Type RESULT
PMID: 24737613 (View on PubMed)

Gordon NF, Gulanick M, Costa F, Fletcher G, Franklin BA, Roth EJ, Shephard T; American Heart Association Council on Clinical Cardiology, Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention; the Council on Cardiovascular Nursing; the Council on Nutrition, Physical Activity, and Metabolism; and the Stroke Council. Physical activity and exercise recommendations for stroke survivors: an American Heart Association scientific statement from the Council on Clinical Cardiology, Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention; the Council on Cardiovascular Nursing; the Council on Nutrition, Physical Activity, and Metabolism; and the Stroke Council. Circulation. 2004 Apr 27;109(16):2031-41. doi: 10.1161/01.CIR.0000126280.65777.A4. No abstract available.

Reference Type RESULT
PMID: 15117863 (View on PubMed)

Schepers VP, Visser-Meily AM, Ketelaar M, Lindeman E. Poststroke fatigue: course and its relation to personal and stroke-related factors. Arch Phys Med Rehabil. 2006 Feb;87(2):184-8. doi: 10.1016/j.apmr.2005.10.005.

Reference Type RESULT
PMID: 16442970 (View on PubMed)

van der Werf SP, van den Broek HL, Anten HW, Bleijenberg G. Experience of severe fatigue long after stroke and its relation to depressive symptoms and disease characteristics. Eur Neurol. 2001;45(1):28-33. doi: 10.1159/000052085.

Reference Type RESULT
PMID: 11150837 (View on PubMed)

Skaner Y, Nilsson GH, Sundquist K, Hassler E, Krakau I. Self-rated health, symptoms of depression and general symptoms at 3 and 12 months after a first-ever stroke: a municipality-based study in Sweden. BMC Fam Pract. 2007 Oct 17;8:61. doi: 10.1186/1471-2296-8-61.

Reference Type RESULT
PMID: 17941995 (View on PubMed)

Kirkevold M, Christensen D, Andersen G, Johansen SP, Harder I. Fatigue after stroke: manifestations and strategies. Disabil Rehabil. 2012;34(8):665-70. doi: 10.3109/09638288.2011.615373. Epub 2011 Oct 13.

Reference Type RESULT
PMID: 21995298 (View on PubMed)

Staub F, Bogousslavsky J. Post-stroke depression or fatigue. Eur Neurol. 2001;45(1):3-5. doi: 10.1159/000052081. No abstract available.

Reference Type RESULT
PMID: 11205620 (View on PubMed)

De Groot MH, Phillips SJ, Eskes GA. Fatigue associated with stroke and other neurologic conditions: Implications for stroke rehabilitation. Arch Phys Med Rehabil. 2003 Nov;84(11):1714-20. doi: 10.1053/s0003-9993(03)00346-0.

Reference Type RESULT
PMID: 14639575 (View on PubMed)

Staub F, Bogousslavsky J. Fatigue after stroke: a major but neglected issue. Cerebrovasc Dis. 2001 Aug;12(2):75-81. doi: 10.1159/000047685.

Reference Type RESULT
PMID: 11490100 (View on PubMed)

Acciarresi M, Bogousslavsky J, Paciaroni M. Post-stroke fatigue: epidemiology, clinical characteristics and treatment. Eur Neurol. 2014;72(5-6):255-61. doi: 10.1159/000363763. Epub 2014 Sep 24.

Reference Type RESULT
PMID: 25277765 (View on PubMed)

Cumming TB, Packer M, Kramer SF, English C. The prevalence of fatigue after stroke: A systematic review and meta-analysis. Int J Stroke. 2016 Dec;11(9):968-977. doi: 10.1177/1747493016669861. Epub 2016 Oct 4.

Reference Type RESULT
PMID: 27703065 (View on PubMed)

Stroke--1989. Recommendations on stroke prevention, diagnosis, and therapy. Report of the WHO Task Force on Stroke and other Cerebrovascular Disorders. Stroke. 1989 Oct;20(10):1407-31. doi: 10.1161/01.str.20.10.1407. No abstract available.

Reference Type RESULT
PMID: 2799873 (View on PubMed)

Aho K, Harmsen P, Hatano S, Marquardsen J, Smirnov VE, Strasser T. Cerebrovascular disease in the community: results of a WHO collaborative study. Bull World Health Organ. 1980;58(1):113-30.

Reference Type RESULT
PMID: 6966542 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

İ07-516-24

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Post-stroke Cognitive Impairment
NCT05653141 ACTIVE_NOT_RECRUITING